Sail Biomedicines, a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced the presentation of preclinical data on its in vivo CAR-T product candidate, SAIL-0804, ...

Are the Galaxy on the way to their first win of the season? They have doubled their lead in Philly! Surely they can't slip ...

FORT MILL, S.C., May 14, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced ...

MediPharm Labs Corp. (MEDIF Q1 2025 Earnings Conference Call May 14, 2025 10:00 AM ETCompany ParticipantsDavid Pidduck - President & Chief ...

CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that new data from a study in non-human primates (NHPs) has ...

Q1 2025 Earnings Call Transcript May 13, 2025 Operator: Good morning, ladies and gentlemen, welcome to Vivo’s First Quarter ...

Looking for a powerful, portable, and stylish ultrabook? Meet the Asus Zenbook A14! In this video, we take a deep dive into ...

Realme's Neo 7 series currently includes the Realme Neo 7, Neo 7 SE, and Neo 7x models. The former was launched in December 2024 with a MediaTek Dimensity 9300+ chipset, while the Neo 7 SE and Neo 7x ...

Cambridge, USA-based biotech Stylus Medicine, which says it is dedicated to developing transformative in vivo genetic ...

Stylus will use the Eli Lilly and J&J-backed funds to advance its in vivo genetic medicines platform and develop its pipeline ...

Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a critical milestone for the treatment of neurological disorders - - ...

Gone are the days we look at cameras as the deciding factor for a brand new phone.  Sure, we still look at that today, but ...